Gsk

GSK grows in Asia vacc market

GSK grows in Asia vacc market

By Gareth Macdonald

UK drug major GSK has had a busy week in the Asia, signing an influenza vaccine manufacturing deal with China’s Shenzhen Neptunus Interlong Bio-Technique just days after it opened a new S$600m (EUR294m) production facility in Singapore.

GSK axe begins to fall

GSK axe begins to fall

By Anna Lewcock

GlaxoSmithKline (GSK) has been swift in implementing its plant
cuts, already announcing the first sites to be axed mere hours
after revealing its restructuring plans.

GSK's thirst for adjuvants grows

GSK's thirst for adjuvants grows

By Gregory Roumeliotis

GlaxoSmithKline (GSK) has asked vaccine developing firm Antigenics
to supply it with more of its QS-21 adjuvant as its vaccines
progress in the pipeline, while at the same the British drug giant
is pushing ahead with its own adjuvant,...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All